Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenchen Feng

Showing results (31-40 of 170) with videos related to

Pageof 17
Sort By:
The International Journal of Health Planning and Management|February 25, 2022
Large hospitals' outpatient diversion system in China: Following individual intention and referralLe Luo, Yuxuan Zhang, Yumeng Zhang, et al.
Wideochirurgia I Inne Techniki Maloinwazyjne = Videosurgery and Other Miniinvasive Techniques|December 21, 2012
Ureteroscopic holmium:YAG laser endopyelotomy is effective in distinctive ureteropelvic junction obstructionsZhong Wu, Chenchen Feng, Qiang Ding, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 22, 2014
Loss of MLH1 confers resistance to PI3Kβ inhibitors in renal clear cell carcinoma with SETD2 mutationChenchen Feng, Guanxiong Ding, Haowen Jiang, et al.
Minerva Pediatrics|March 14, 2023
The effect of the comfort care model on the quality of life and improvement of elderly patients with cardiovascular diseasesJinhua Jin, Jun Xie, Linlin Bian, et al.
Food Research International (Ottawa, Ont.)|October 3, 2021
Novel insight into physicochemical and flavor formation in koumiss based on microbial metabolic networkYanan Xia, Jiaqi Yu, Hao Liu, et al.
The Journal of International Medical Research|November 29, 2019
Treatment-related adverse events and response rate to immune checkpoint inhibitionYanmin Li, Zhengping Wang, Ting Guo, et al.
Clinical and Translational Medicine|March 30, 2021
BCL2L2 loss renders -14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitorsYinfeng Lyu, Kunping Li, Yuqing Li, et al.
Oncology Reports|March 8, 2018
Knockdown of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) enhances tumorigenesis both in vivo and in vitro in bladder cancerShenghua Liu, Haowen Jiang, Hui Wen, et al.
Clinical and Translational Medicine|May 20, 2023
Correction to: BCL2L2 loss renders -14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitorsYinfeng Lyu, Kunping Li, Yuqing Li, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 3, 2013
Relationship of TP53 and Ki67 expression in bladder cancer under WHO 2004 classificationLujia Wang, Chenchen Feng, Guanxiong Ding, et al.
Pageof 17

Showing results (31-40 of 170) with videos related to

Sort By:
Pageof 17
The International Journal of Health Planning and Management|February 25, 2022
Large hospitals' outpatient diversion system in China: Following individual intention and referralLe Luo, Yuxuan Zhang, Yumeng Zhang, et al.
Wideochirurgia I Inne Techniki Maloinwazyjne = Videosurgery and Other Miniinvasive Techniques|December 21, 2012
Ureteroscopic holmium:YAG laser endopyelotomy is effective in distinctive ureteropelvic junction obstructionsZhong Wu, Chenchen Feng, Qiang Ding, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 22, 2014
Loss of MLH1 confers resistance to PI3Kβ inhibitors in renal clear cell carcinoma with SETD2 mutationChenchen Feng, Guanxiong Ding, Haowen Jiang, et al.
Minerva Pediatrics|March 14, 2023
The effect of the comfort care model on the quality of life and improvement of elderly patients with cardiovascular diseasesJinhua Jin, Jun Xie, Linlin Bian, et al.
Food Research International (Ottawa, Ont.)|October 3, 2021
Novel insight into physicochemical and flavor formation in koumiss based on microbial metabolic networkYanan Xia, Jiaqi Yu, Hao Liu, et al.
The Journal of International Medical Research|November 29, 2019
Treatment-related adverse events and response rate to immune checkpoint inhibitionYanmin Li, Zhengping Wang, Ting Guo, et al.
Clinical and Translational Medicine|March 30, 2021
BCL2L2 loss renders -14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitorsYinfeng Lyu, Kunping Li, Yuqing Li, et al.
Oncology Reports|March 8, 2018
Knockdown of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) enhances tumorigenesis both in vivo and in vitro in bladder cancerShenghua Liu, Haowen Jiang, Hui Wen, et al.
Clinical and Translational Medicine|May 20, 2023
Correction to: BCL2L2 loss renders -14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitorsYinfeng Lyu, Kunping Li, Yuqing Li, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 3, 2013
Relationship of TP53 and Ki67 expression in bladder cancer under WHO 2004 classificationLujia Wang, Chenchen Feng, Guanxiong Ding, et al.
Pageof 17